← SynDRA
PHA-543613
SynDRA canonical compound SYN0006293 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CHRNA7 |
|---|
| Mechanism of action | nicotinic receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- CHRNA7 AGONIST
- Neuronal acetylcholine receptor protein alpha-7 subunit agonist
- nicotinic receptor agonist
Cross-references
Synonyms
- Pha-00543613
- J3.179.420J
- PHA-543,613
- (R)-N-(Quinuclidin-3-yl)furo(2,3-C)pyridine-5-carboxamide
- R36R9KVD6Y
- PHA-00543613
- DTXCID4027284
- (R)-N-(quinuclidin-3-yl)furo[2,3-c]pyridine-5-carboxamide
- RefChem:860497
- PHA543613
- UNII-R36R9KVD6Y
- GTPL3998
- orb1704236
- SCHEMBL2596554
- CHEBI:167763
- IPKZCLGGYKRDES-ZDUSSCGKSA-N
- EX-A7286
- Tox21_300448
- BDBM50190786
- AKOS005146334
- EBC-224058
- NCGC00248050-01
- NCGC00254368-01
- DA-66649
- MS-23841
- HY-105670
- CAS-478149-53-0
- CS-0026424
- F82142
- T23145
- PHA-543613, >=98% (HPLC)
- N-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]furo[2,3-c]pyridine-5-carboxamide
- PHA-543613F
- 5Qat734klh
- PHA543613F
- PHA-543613 FUMARATE
- PHA-543613 dihydrochloride salt
- SCHEMBL6007449
- UNII-Z7950E6X01
Look up PHA-543613 in the interactive SynDRA portal →